Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
CHA University
CHA University
AstraZeneca
National Institutes of Health Clinical Center (CC)
Eisai Inc.
AstraZeneca
Tata Memorial Centre
Institute of Liver and Biliary Sciences, India
CHA University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
GERCOR - Multidisciplinary Oncology Cooperative Group
Tongji Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
University of Colorado, Denver
Tongji Hospital